Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.23 is 63% above its 5-year average of -0.62, near the high end of its 5-year range (-1.52–-0.17).
6.98% below its 12-month average of -0.22.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:35:42.135Z. Historical observations retain their original dates. Historical series through 2015-11-12.
EARNINGS PER SHARE (EPS)
-0.23
EARNINGS PER SHARE (EPS) AVG TTM
-0.22
EARNINGS PER SHARE (EPS) AVG 3Y
-0.29
EARNINGS PER SHARE (EPS) AVG 5Y
-0.62
EARNINGS PER SHARE (EPS) AVG 10Y
-1.11
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.98%
CURRENT VS 3Y AVG
+20.00%
CURRENT VS 5Y AVG
+62.90%
CURRENT VS 10Y AVG
+79.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Ardelyx, Inc.
Market Cap
$810.26M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.22
3Y Avg
-0.29
5Y Avg
-0.62
Market Cap
$802.74M
Earnings Per Share (EPS)
-2.75
TTM Avg
-44.66
3Y Avg
-65.84
5Y Avg
-51.72
Market Cap
$826.01M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.54
3Y Avg
-1.41
5Y Avg
-1.41
Market Cap
$832.12M
Earnings Per Share (EPS)
-2.18
TTM Avg
-0.78
3Y Avg
-1.63
5Y Avg
-1.49
Market Cap
$787.11M
Earnings Per Share (EPS)
-0.20
TTM Avg
0.10
3Y Avg
-0.30
5Y Avg
-1.16
Market Cap
$840.18M
Earnings Per Share (EPS)
-0.43
TTM Avg
-1.48
3Y Avg
-1.39
5Y Avg
-1.04
Market Cap
$836.87M
Earnings Per Share (EPS)
-3.80
TTM Avg
-6.69
3Y Avg
-9.43
5Y Avg
-9.43
Market Cap
$838.84M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.25
3Y Avg
-1.25
5Y Avg
-1.25
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $810.26M | -0.23 | -0.22 | -0.29 | -0.62 |
| Jade Biosciences, Inc. (JBIO)vs › | $802.74M | -2.75 | -44.66 | -65.84 | -51.72 |
| InMode Ltd. (INMD)vs › | $802.64M | 1.23 | 1.87 | 2.02 | 1.86 |
| Beta Bionics, Inc. (BBNX)vs › | $826.01M | -1.68 | -1.54 | -1.41 | -1.41 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $832.12M | -2.18 | -0.78 | -1.63 | -1.49 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $787.11M | -0.20 | 0.10 | -0.30 | -1.16 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $840.18M | -0.43 | -1.48 | -1.39 | -1.04 |
| Alumis Inc. (ALMS)vs › | $836.87M | -3.80 | -6.69 | -9.43 | -9.43 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $838.84M | N/A | -1.25 | -1.25 | -1.25 |
| Geron Corporation (GERN)vs › | $779.45M | -0.10 | -0.20 | -0.27 | -0.29 |
Trailing EPS (TTM)
$-0.23
Forward EPS (Est.)
$-0.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.26 |
| 2024-12-31 | -0.17 |
| 2023-12-31 | -0.30 |
| 2022-12-31 | -0.42 |
| 2021-12-31 | -1.52 |
| 2020-12-31 | -1.05 |
| 2019-12-31 | -1.47 |
| 2018-12-31 | -1.62 |
| 2017-12-31 | -1.36 |
| 2016-12-31 | -2.80 |
| 2015-12-31 | -1.29 |
| 2014-12-31 | -0.17 |
| 2013-12-31 | -0.49 |
| 2012-12-31 | -0.73 |
